Indonesia approves China's Sinovac shot for ages 12 to 17

2021-06-29 12:00:00

(Asian Tech Press) Indonesia has approved China's Sinovac shot for ages 12 to 17, according to Indonesian media reports.

On June 27, local time, Indonesia's food and drug authority approved the COVID-19 vaccine, which is developed by China's Sinovac Biotech Ltd, for emergency use in the country's population aged 12-17.

Joko Widodo, the president of Indonesia, announced on Monday that the country will start vaccinating minors between 12 and 17 years old with the Sinovac COVID-19 vaccine.

Chinese Vaccine Indonesia Sinovac Vaccine COVID

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Tencent Holdings repurchased 3.93 million shares for HK$1.5 billion on January 7
                            2025-01-07

                                    Ireland recorded a 12.8 billion euro fiscal surplus last year due to the "Apple tax" ruling
                            2025-01-07

                                    Ministry of Industry and Information Technology: Promoting technical verification of 10G optical network and artificial intelligence integration
                            2025-01-07

                                    Tencent's major shareholder Prosus reduced its stake in Tencent Holdings from 24.01% to 23.99% on January 6.
                            2025-01-07

                                    U.S. chip stocks rose before the market opened, with Nvidia up 0.6%
                            2025-01-07